MACM
MNTA

March Altus Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

March Altus Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-103,729
Closed -$1.18M – 32
2014
Q3 		$1.18M Buy
+103,729
New +$1.18M 0.47% 24

Other funds holding MNTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

March Altus Capital Management's MNTA Position: Q4 2014 in Review

March Altus Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2014, closing a stake of 103,729 shares — an estimated $1.18M sold.

March Altus Capital Management first reported a position in MNTA in Q3 2014 and held it in 1 quarter. The position peaked at $1.18M in Q3 2014. 148 funds tracked by Wall St. Rank hold MNTA as of Q4 2014.

  • March Altus Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • March Altus Capital Management sold 103,729 Momenta Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.18M.
  • March Altus Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • March Altus Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.18M in Q3 2014.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2014.

Based on March Altus Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.